Advanced Oncotherapy in talks to buy company with new cancer treatment technology

Advanced Oncotherapy has signed a heads of terms to acquire an undisclosed company that has developed state of the art technology for treating cancerous tumours.

Advanced Oncotherapy has signed a heads of terms to acquire an undisclosed company that has developed state of the art technology for treating cancerous tumours.

The technology uses proton beam therapy (PBT), a form of radiation treatment for cancers which avoids harm to critical organs and tissues and reduces side effects commonly associated with traditional radiation therapies.

While PBT is the preferred radiation treatment, there are only 32 centres operating around the world due to the costs and size of facilities.

"Advanced Oncotherapy's target acquisition has, with one of the world's leading scientific establishments, concentrated on developing a low cost affordable system capable of providing PBT treatment to a large number of hospitals," the company said in a statement.

The new technology, which is based on radio frequency linear accelerators (linacs), does not need a absorber to adjust the energy to the depth of the tumour. The adjustment can be made electronically in only one hundredth of a second, instead of the second required by synchrotrons. The technology is therefore efficient and easy to maintain.

Linacs are well-suited for cost reductions in mass production as they are very light and can be pre-mounted before transportation, with a significant reduction in the installation time on site.

The proposed acquisition is subject to the completion of mutual due diligence by both parties.

Shares jumped 8.33% to 0.98p at 10:58 Monday.

RD

Recommended

HubSpot: a tech stock set to tumble
Trading

HubSpot: a tech stock set to tumble

US tech stocks have had a fantastic couple of years. But this year is unlikely to be so bullish for high-fliers that can’t turn big profits.
18 Jan 2022
How to be better at selling stocks
Investment strategy

How to be better at selling stocks

There is plenty of advice around about buying stocks, but not so much about when you should sell. John Stepek explains the two key things to know abou…
14 Jan 2022
Share tips of the week – 14 January
Share tips

Share tips of the week – 14 January

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
14 Jan 2022
Fintech: how to profit as technology transforms banking around the world
Share tips

Fintech: how to profit as technology transforms banking around the world

Financial technology – from apps to APIs to the cloud – is rapidly transforming financial services. This will spell doom for some incumbent firms, whi…
14 Jan 2022

Most Popular

US inflation is at its highest since 1982. Why aren’t markets panicking?
Inflation

US inflation is at its highest since 1982. Why aren’t markets panicking?

US inflation is at 7% – the last time it was this high interest rates were at 14%. But instead of panicking, markets just shrugged. John Stepek explai…
13 Jan 2022
Interest rates might rise faster than expected – what does that mean for your money?
Global Economy

Interest rates might rise faster than expected – what does that mean for your money?

The idea that the US Federal Reserve could raise interest rates much earlier than anticipated has upset the markets. John Stepek explains why, and wha…
6 Jan 2022
Tech stocks teeter as US Treasury bond yields rise
Tech stocks

Tech stocks teeter as US Treasury bond yields rise

The realisation that central banks are about to tighten their monetary policies caused a sell-off in the tech-heavy Nasdaq stock index and the biggest…
14 Jan 2022